2004, 1st ed., ISBN 9780385500586, x, 241
Book
1998, ISBN 9780385485838, 355
Book
1994, ISBN 0671887246, 272
Book
1999, BMS explained, ISBN 0750634154, 202
Book
Current HIV Research, ISSN 1570-162X, 04/2004, Volume 2, Issue 2, pp. 99 - 111
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2011, Volume 56, p. 64
Journal Article
Psychological science, ISSN 0956-7976, 07/2009, Volume 20, Issue 7, pp. 831 - 837
Gene-environment interactions involving exogenous environmental factors are known to shape behavior and personality development. Although gene-environment...
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e78817
Sexual transmission of human immunodeficiency virus type 1 (HIV-1) across the cervicovaginal mucosa in women is influenced by many factors including the...
COITAL-ACT | STRAINS | SEXUALLY-TRANSMITTED-DISEASES | HIV-INFECTION | FLORA | MULTIDISCIPLINARY SCIENCES | ACQUISITION | HUMAN-IMMUNODEFICIENCY-VIRUS | EXPRESSION | GENITAL-TRACT INFLAMMATION | BACTERIAL VAGINOSIS | Coinfection | Menstrual Cycle | Vaginitis - microbiology | Macaca mulatta | Simian Acquired Immunodeficiency Syndrome - microbiology | Anti-Infective Agents, Local | Microbiota | Simian Acquired Immunodeficiency Syndrome - virology | Disease Susceptibility - immunology | Inflammation Mediators - metabolism | Female | Simian Acquired Immunodeficiency Syndrome - transmission | Disease Models, Animal | Simian Immunodeficiency Virus - immunology | Vaginitis - metabolism | Biomarkers - metabolism | Cytokines - metabolism | Mucous Membrane - virology | Carrier Proteins - biosynthesis | Risk Factors | Lactobacillus - metabolism | Mucous Membrane - metabolism | Simian Acquired Immunodeficiency Syndrome - prevention & control | Animals | Vagina - virology | Vaginitis - immunology | Bacterial Proteins - biosynthesis | Vagina - microbiology | Vaginitis - virology | Mucous Membrane - microbiology | Hydrogen-Ion Concentration | Interleukins | Microbiota (Symbiotic organisms) | Analysis | Anti-infective agents | Models | Inflammation | HIV (Viruses) | Cyanovirin-N | Sexually transmitted diseases--STD | Toxicity | Mucosa | Interleukin | Viruses | Sexual transmission | Infections | Interleukin 1 receptors | pH effects | Autophagy | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Interleukin 1 | pH | Biocompatibility | Cytokines | Interleukin 1 receptor antagonist | Peak load | Lactobacilli | Vagina | Interleukin 13 | Environmental impact | Strain | Disease transmission | Womens health | Biomarkers | Colonization | Cancer | STD | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
COITAL-ACT | STRAINS | SEXUALLY-TRANSMITTED-DISEASES | HIV-INFECTION | FLORA | MULTIDISCIPLINARY SCIENCES | ACQUISITION | HUMAN-IMMUNODEFICIENCY-VIRUS | EXPRESSION | GENITAL-TRACT INFLAMMATION | BACTERIAL VAGINOSIS | Coinfection | Menstrual Cycle | Vaginitis - microbiology | Macaca mulatta | Simian Acquired Immunodeficiency Syndrome - microbiology | Anti-Infective Agents, Local | Microbiota | Simian Acquired Immunodeficiency Syndrome - virology | Disease Susceptibility - immunology | Inflammation Mediators - metabolism | Female | Simian Acquired Immunodeficiency Syndrome - transmission | Disease Models, Animal | Simian Immunodeficiency Virus - immunology | Vaginitis - metabolism | Biomarkers - metabolism | Cytokines - metabolism | Mucous Membrane - virology | Carrier Proteins - biosynthesis | Risk Factors | Lactobacillus - metabolism | Mucous Membrane - metabolism | Simian Acquired Immunodeficiency Syndrome - prevention & control | Animals | Vagina - virology | Vaginitis - immunology | Bacterial Proteins - biosynthesis | Vagina - microbiology | Vaginitis - virology | Mucous Membrane - microbiology | Hydrogen-Ion Concentration | Interleukins | Microbiota (Symbiotic organisms) | Analysis | Anti-infective agents | Models | Inflammation | HIV (Viruses) | Cyanovirin-N | Sexually transmitted diseases--STD | Toxicity | Mucosa | Interleukin | Viruses | Sexual transmission | Infections | Interleukin 1 receptors | pH effects | Autophagy | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Interleukin 1 | pH | Biocompatibility | Cytokines | Interleukin 1 receptor antagonist | Peak load | Lactobacilli | Vagina | Interleukin 13 | Environmental impact | Strain | Disease transmission | Womens health | Biomarkers | Colonization | Cancer | STD | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Psychological Science, ISSN 0956-7976, 7/2009, Volume 20, Issue 7, pp. 831 - 837
Gene-environment interactions involving exogenous environmental factors are known to shape behavior and personality development. Although geneenvironment...
Receptors | Child development | Molecular genetics | Alleles | Medical genetics | Electroencephalography | Children | Temperament | Human genetics | Genotypes | SOCIAL-BEHAVIOR | MOLECULAR-GENETICS | PSYCHOLOGY, MULTIDISCIPLINARY | ATTACHMENT DISORGANIZATION | EARLY-CHILDHOOD | NOVELTY SEEKING | EXTERNALIZING BEHAVIOR | EEG ASYMMETRY | DIFFERENTIAL SUSCEPTIBILITY | DOPAMINE-D4 RECEPTOR DRD4 | ENVIRONMENTAL-INFLUENCES | Infant Behavior - physiology | Humans | Child, Preschool | Infant | Behavior - physiology | Brain - physiology | Electroencephalography - methods | Receptors, Dopamine D4 - genetics | Frontal Lobe - physiology | Temperament - physiology | Functional Laterality - physiology | Longitudinal Studies | Neurosciences | Genetic aspects | Dopamine receptors | Behavior | Asymmetry | Genes | Personality traits | Genotype & phenotype | Child psychology
Receptors | Child development | Molecular genetics | Alleles | Medical genetics | Electroencephalography | Children | Temperament | Human genetics | Genotypes | SOCIAL-BEHAVIOR | MOLECULAR-GENETICS | PSYCHOLOGY, MULTIDISCIPLINARY | ATTACHMENT DISORGANIZATION | EARLY-CHILDHOOD | NOVELTY SEEKING | EXTERNALIZING BEHAVIOR | EEG ASYMMETRY | DIFFERENTIAL SUSCEPTIBILITY | DOPAMINE-D4 RECEPTOR DRD4 | ENVIRONMENTAL-INFLUENCES | Infant Behavior - physiology | Humans | Child, Preschool | Infant | Behavior - physiology | Brain - physiology | Electroencephalography - methods | Receptors, Dopamine D4 - genetics | Frontal Lobe - physiology | Temperament - physiology | Functional Laterality - physiology | Longitudinal Studies | Neurosciences | Genetic aspects | Dopamine receptors | Behavior | Asymmetry | Genes | Personality traits | Genotype & phenotype | Child psychology
Journal Article
Science, ISSN 0036-8075, 11/1996, Volume 274, Issue 5292, pp. 1527 - 1531
Transporter-facilitated uptake of serotonin (5-hydroxytryptamine or 5-HT) has been implicated in anxiety in humans and animal models and is the site of action...
Messenger RNA | Anxiety disorders | Serotonin receptors | Genes | Cell lines | Personality traits | Reports | Anxiety | Genotypes | Phenotypic traits | Siblings | H-3 PAROXETINE BINDING | QUANTITATIVE TRAITS | UNIFIED BIOSOCIAL THEORY | MYOCARDIAL-INFARCTION | MULTIDISCIPLINARY SCIENCES | PERSONALITY-DISORDERS | MARKERS | MAJOR DEPRESSION | LINKAGE | ANGIOTENSIN-CONVERTING ENZYME | SEXUAL ORIENTATION | Cell Line | Promoter Regions, Genetic | Humans | Middle Aged | Nuclear Family | Genotype | Male | Nerve Tissue Proteins | Neurotic Disorders - genetics | Serotonin Plasma Membrane Transport Proteins | Genetic Markers | Membrane Glycoproteins - genetics | Polymorphism, Genetic | Carrier Proteins - genetics | Phenotype | Transfection | Membrane Transport Proteins | Serotonin - metabolism | Adolescent | Alleles | Personality Tests | Adult | Anxiety Disorders - genetics | Female | Genetic aspects | Personality | Research | Serotonin | Neuroses | Anxieties | Biochemistry
Messenger RNA | Anxiety disorders | Serotonin receptors | Genes | Cell lines | Personality traits | Reports | Anxiety | Genotypes | Phenotypic traits | Siblings | H-3 PAROXETINE BINDING | QUANTITATIVE TRAITS | UNIFIED BIOSOCIAL THEORY | MYOCARDIAL-INFARCTION | MULTIDISCIPLINARY SCIENCES | PERSONALITY-DISORDERS | MARKERS | MAJOR DEPRESSION | LINKAGE | ANGIOTENSIN-CONVERTING ENZYME | SEXUAL ORIENTATION | Cell Line | Promoter Regions, Genetic | Humans | Middle Aged | Nuclear Family | Genotype | Male | Nerve Tissue Proteins | Neurotic Disorders - genetics | Serotonin Plasma Membrane Transport Proteins | Genetic Markers | Membrane Glycoproteins - genetics | Polymorphism, Genetic | Carrier Proteins - genetics | Phenotype | Transfection | Membrane Transport Proteins | Serotonin - metabolism | Adolescent | Alleles | Personality Tests | Adult | Anxiety Disorders - genetics | Female | Genetic aspects | Personality | Research | Serotonin | Neuroses | Anxieties | Biochemistry
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2005, Volume 102, Issue 34, pp. 11993 - 11998
Most HIV transmission occurs on the mucosal surfaces of the gastrointestinal and cervicovaginal tracts, both of which are normally coated by a biofilm of...
Proteins | Biological Sciences | Genetically engineered microorganisms | HIV | Antibiotics | Secretion | Plasmids | Bacteria | Viruses | Bacterial colonization | Feces | Prevention | Microbicide | Bacterial | AIDS | Nissle 1917 | SYSTEM | AIDS prevention | MULTIDISCIPLINARY SCIENCES | ULCERATIVE-COLITIS | GASTROINTESTINAL-TRACT | COLONIZATION | MESALAZINE | bacterial | microbicide | DISEASE | INFECTION | MAINTAINING REMISSION | ESCHERICHIA-COLI STRAIN | Anti-HIV Agents - pharmacology | Genetic Engineering - methods | HIV Infections - prevention & control | Humans | HIV Envelope Protein gp41 - metabolism | Cecum - microbiology | Intestinal Mucosa - microbiology | HIV - drug effects | Peptides - pharmacology | Animals | Escherichia coli - genetics | Models, Biological | Escherichia coli - metabolism | Female | HIV - metabolism | Peptides - secretion | Colon - microbiology | Mice | Vagina - microbiology | Anti-HIV Agents - metabolism | Hemolysin Proteins - metabolism | Genetic aspects | Research | HIV (Viruses) | prevention
Proteins | Biological Sciences | Genetically engineered microorganisms | HIV | Antibiotics | Secretion | Plasmids | Bacteria | Viruses | Bacterial colonization | Feces | Prevention | Microbicide | Bacterial | AIDS | Nissle 1917 | SYSTEM | AIDS prevention | MULTIDISCIPLINARY SCIENCES | ULCERATIVE-COLITIS | GASTROINTESTINAL-TRACT | COLONIZATION | MESALAZINE | bacterial | microbicide | DISEASE | INFECTION | MAINTAINING REMISSION | ESCHERICHIA-COLI STRAIN | Anti-HIV Agents - pharmacology | Genetic Engineering - methods | HIV Infections - prevention & control | Humans | HIV Envelope Protein gp41 - metabolism | Cecum - microbiology | Intestinal Mucosa - microbiology | HIV - drug effects | Peptides - pharmacology | Animals | Escherichia coli - genetics | Models, Biological | Escherichia coli - metabolism | Female | HIV - metabolism | Peptides - secretion | Colon - microbiology | Mice | Vagina - microbiology | Anti-HIV Agents - metabolism | Hemolysin Proteins - metabolism | Genetic aspects | Research | HIV (Viruses) | prevention
Journal Article
13.
Full Text
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
Mucosal Immunology, ISSN 1933-0219, 11/2011, Volume 4, Issue 6, pp. 648 - 657
Most human immunodeficiency virus (HIV) transmissions in women occur through the cervicovaginal mucosa, which is coated by a bacterial biofilm including...
SOUTH-AFRICA | CYANOVIRIN-N | ACQUISITION | IMMUNODEFICIENCY-VIRUS TYPE-1 | ANIMAL-MODEL | IMMUNOLOGY | HIV-1 INFECTION | MICROBICIDE TRIALS | SEXUAL TRANSMISSION | RHESUS MACAQUES | BACTERIAL VAGINOSIS | Lactobacillus - genetics | Lactobacillus - growth & development | Humans | Vagina - immunology | Administration, Intravaginal | HIV - immunology | Macaca mulatta | Viral Load | Virus Internalization | HIV Infections - immunology | HIV Infections - microbiology | Simian Immunodeficiency Virus - genetics | Female | HIV Infections - transmission | Bacterial Proteins - immunology | Immunity, Mucosal - genetics | Carrier Proteins - immunology | Cytokines - blood | Disease Models, Animal | Lactobacillus - immunology | Bacterial Proteins - genetics | HIV - pathogenicity | Lactobacillus - metabolism | Carrier Proteins - genetics | Animals | Carrier Proteins - metabolism | Genetic Engineering | Recombinant Fusion Proteins - genetics | Bacterial Proteins - metabolism | HIV - genetics | Vagina - metabolism | Vagina - microbiology
SOUTH-AFRICA | CYANOVIRIN-N | ACQUISITION | IMMUNODEFICIENCY-VIRUS TYPE-1 | ANIMAL-MODEL | IMMUNOLOGY | HIV-1 INFECTION | MICROBICIDE TRIALS | SEXUAL TRANSMISSION | RHESUS MACAQUES | BACTERIAL VAGINOSIS | Lactobacillus - genetics | Lactobacillus - growth & development | Humans | Vagina - immunology | Administration, Intravaginal | HIV - immunology | Macaca mulatta | Viral Load | Virus Internalization | HIV Infections - immunology | HIV Infections - microbiology | Simian Immunodeficiency Virus - genetics | Female | HIV Infections - transmission | Bacterial Proteins - immunology | Immunity, Mucosal - genetics | Carrier Proteins - immunology | Cytokines - blood | Disease Models, Animal | Lactobacillus - immunology | Bacterial Proteins - genetics | HIV - pathogenicity | Lactobacillus - metabolism | Carrier Proteins - genetics | Animals | Carrier Proteins - metabolism | Genetic Engineering | Recombinant Fusion Proteins - genetics | Bacterial Proteins - metabolism | HIV - genetics | Vagina - metabolism | Vagina - microbiology
Journal Article
Journal of Virology, ISSN 0022-538X, 2017, Volume 91, Issue 3
The envelope (Env) glycoprotein of HIV is expressed on the surface of productively infected cells and can be used as a target for cytotoxic immunoconjugates...
Monoclonal antibodies | Immunotoxins | Immunoglobulins | Human immunodeficiency virus | Antibody drug conjugate | PHASE 1/2 | ENVELOPE GLYCOPROTEIN | ANTIRETROVIRAL THERAPY | immunoglobulins | HUMAN-IMMUNODEFICIENCY-VIRUS | RICIN-A-CHAIN | VIROLOGY | IMMUNOTOXIN | MOUSE MODEL | human immunodeficiency virus | antibody drug conjugate | immunotoxins | MONOCLONAL-ANTIBODIES | PSEUDOMONAS EXOTOXIN | DEGLYCOSYLATED RICIN | monoclonal antibodies | Anti-HIV Agents - pharmacology | Macaca nemestrina | HIV-1 - drug effects | HIV Infections - virology | Humans | Cells, Cultured | Polyethylene Glycols - chemistry | Immunotoxins - pharmacology | Immunoconjugates - chemistry | Anti-HIV Agents - chemistry | Immunoconjugates - pharmacology | Animals | HIV Envelope Protein gp160 - antagonists & inhibitors | Drug Design | HIV Infections - drug therapy | HIV Envelope Protein gp160 - immunology | Mice | Antibodies, Monoclonal - immunology | Disease Models, Animal | Index Medicus
Monoclonal antibodies | Immunotoxins | Immunoglobulins | Human immunodeficiency virus | Antibody drug conjugate | PHASE 1/2 | ENVELOPE GLYCOPROTEIN | ANTIRETROVIRAL THERAPY | immunoglobulins | HUMAN-IMMUNODEFICIENCY-VIRUS | RICIN-A-CHAIN | VIROLOGY | IMMUNOTOXIN | MOUSE MODEL | human immunodeficiency virus | antibody drug conjugate | immunotoxins | MONOCLONAL-ANTIBODIES | PSEUDOMONAS EXOTOXIN | DEGLYCOSYLATED RICIN | monoclonal antibodies | Anti-HIV Agents - pharmacology | Macaca nemestrina | HIV-1 - drug effects | HIV Infections - virology | Humans | Cells, Cultured | Polyethylene Glycols - chemistry | Immunotoxins - pharmacology | Immunoconjugates - chemistry | Anti-HIV Agents - chemistry | Immunoconjugates - pharmacology | Animals | HIV Envelope Protein gp160 - antagonists & inhibitors | Drug Design | HIV Infections - drug therapy | HIV Envelope Protein gp160 - immunology | Mice | Antibodies, Monoclonal - immunology | Disease Models, Animal | Index Medicus
Journal Article
Nicotine and Tobacco Research, ISSN 1462-2203, 2002, Volume 4, Issue 1, pp. 115 - 125
Journal Article
Immunity, ISSN 1074-7613, 2003, Volume 19, Issue 3, pp. 413 - 423
Antiretroviral therapy is unable to eliminate HIV infection in a small, long-lived population of latently infected T cells, providing a source for renewed...
INFECTED INDIVIDUALS | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | IN-VIVO | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENVELOPE GLYCOPROTEIN | CD4(+) T-CELLS | SCID-HU MOUSE | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | HUMAN HEMATOLYMPHOID DIFFERENTIATION | Immunotoxins - immunology | Adjuvants, Immunologic - pharmacology | Interleukin-7 - pharmacology | HIV-1 - genetics | Mice, SCID | T-Lymphocytes - virology | Virus Latency - physiology | Animals | HIV-1 - physiology | T-Lymphocytes - drug effects | Immunotoxins - metabolism | HIV Core Protein p24 - metabolism | Phorbol Esters - pharmacology | T-Lymphocytes - immunology | Mice | HIV Infections - metabolism | Acquired immune deficiency syndrome--AIDS | Pathogenesis | Lymphocytes | Human immunodeficiency virus--HIV | Cell cycle | Population | Drug resistance | Gene expression | Experiments
INFECTED INDIVIDUALS | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | IN-VIVO | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENVELOPE GLYCOPROTEIN | CD4(+) T-CELLS | SCID-HU MOUSE | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | HUMAN HEMATOLYMPHOID DIFFERENTIATION | Immunotoxins - immunology | Adjuvants, Immunologic - pharmacology | Interleukin-7 - pharmacology | HIV-1 - genetics | Mice, SCID | T-Lymphocytes - virology | Virus Latency - physiology | Animals | HIV-1 - physiology | T-Lymphocytes - drug effects | Immunotoxins - metabolism | HIV Core Protein p24 - metabolism | Phorbol Esters - pharmacology | T-Lymphocytes - immunology | Mice | HIV Infections - metabolism | Acquired immune deficiency syndrome--AIDS | Pathogenesis | Lymphocytes | Human immunodeficiency virus--HIV | Cell cycle | Population | Drug resistance | Gene expression | Experiments
Journal Article
PLoS ONE, 11/2013, Volume 8, Issue 11
Sexual transmission of human immunodeficiency virus type 1 (HIV-1) across the cervicovaginal mucosa in women is influenced by many factors including the...
Journal Article
Human Genetics, ISSN 0340-6717, 3/2005, Volume 116, Issue 4, pp. 272 - 278
This is the first report of a full genome scan of sexual orientation in men. A sample of 456 individuals from 146 families with two or more gay brothers was...
LifeSciences | CHROMOSOME | NUCLEI | GENE | HOMOSEXUAL-MEN | GENETICS & HEREDITY | MARKERS | RECEPTOR | POPULATIONS | RELEASE | LINKAGE | EXPRESSION | Chromosomes, Human, X | Homosexuality, Male | Humans | Genotype | Male | Genome, Human | Lod Score
LifeSciences | CHROMOSOME | NUCLEI | GENE | HOMOSEXUAL-MEN | GENETICS & HEREDITY | MARKERS | RECEPTOR | POPULATIONS | RELEASE | LINKAGE | EXPRESSION | Chromosomes, Human, X | Homosexuality, Male | Humans | Genotype | Male | Genome, Human | Lod Score
Journal Article
Journal of Virology, ISSN 0022-538X, 2017, Volume 91, Issue 3
The envelope (Env) glycoprotein of HIV is the only intact viral protein expressed on the surface of both virions and infected cells. Env is the target of...
HIV envelope | Immunotoxin | Monoclonal antibody | Epitope | Gp160 | V3 LOOP | NEUTRALIZING ANTIBODIES | POTENT NEUTRALIZATION | GP41 | FUSION INHIBITOR T-20 | ANTIRETROVIRAL THERAPY | CONFORMATIONAL DYNAMICS | DIFFERENT EPITOPES | VIROLOGY | immunotoxin | IMMUNODEFICIENCY-VIRUS TYPE-1 | epitope | monoclonal antibody | gp160 | T-CELLS | Cell Line | HIV Infections - virology | Humans | Protein Multimerization | Neutralization Tests | Immunotoxins - pharmacology | Epitopes - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | HIV Envelope Protein gp160 - antagonists & inhibitors | Protein Binding | HIV Infections - drug therapy | HIV Envelope Protein gp160 - immunology | Antibodies, Monoclonal - immunology | HIV Envelope Protein gp160 - metabolism |
HIV envelope | Immunotoxin | Monoclonal antibody | Epitope | Gp160 | V3 LOOP | NEUTRALIZING ANTIBODIES | POTENT NEUTRALIZATION | GP41 | FUSION INHIBITOR T-20 | ANTIRETROVIRAL THERAPY | CONFORMATIONAL DYNAMICS | DIFFERENT EPITOPES | VIROLOGY | immunotoxin | IMMUNODEFICIENCY-VIRUS TYPE-1 | epitope | monoclonal antibody | gp160 | T-CELLS | Cell Line | HIV Infections - virology | Humans | Protein Multimerization | Neutralization Tests | Immunotoxins - pharmacology | Epitopes - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | HIV Envelope Protein gp160 - antagonists & inhibitors | Protein Binding | HIV Infections - drug therapy | HIV Envelope Protein gp160 - immunology | Antibodies, Monoclonal - immunology | HIV Envelope Protein gp160 - metabolism |